Vir Biotechnology, Inc. (VIR)
8.39
-0.48
(-5.41%)
USD |
NASDAQ |
Nov 20, 16:00
8.38
-0.01
(-0.12%)
After-Hours: 20:00
Vir Biotechnology Price to Book Value : 1.586 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.586 |
| November 19, 2026 | 1.677 |
| November 18, 2026 | 1.73 |
| November 17, 2026 | 1.749 |
| November 16, 2026 | 1.811 |
| November 13, 2026 | 1.883 |
| November 12, 2026 | 2.292 |
| November 11, 2026 | 2.482 |
| November 10, 2026 | 2.486 |
| November 09, 2026 | 2.580 |
| November 06, 2026 | 2.309 |
| November 05, 2026 | 2.084 |
| November 04, 2026 | 2.225 |
| November 03, 2026 | 2.121 |
| November 02, 2026 | 2.080 |
| October 30, 2026 | 2.136 |
| October 29, 2026 | 2.222 |
| October 28, 2026 | 2.256 |
| October 27, 2026 | 2.188 |
| October 26, 2026 | 2.087 |
| October 23, 2026 | 1.998 |
| October 22, 2026 | 1.972 |
| October 21, 2026 | 1.998 |
| October 20, 2026 | 2.031 |
| October 19, 2026 | 1.930 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.883 |
| October 15, 2026 | 1.980 |
| October 14, 2026 | 1.968 |
| October 13, 2026 | 2.006 |
| October 12, 2026 | 2.136 |
| October 09, 2026 | 2.212 |
| October 08, 2026 | 2.102 |
| October 07, 2026 | 2.178 |
| October 06, 2026 | 2.193 |
| October 05, 2026 | 2.227 |
| October 02, 2026 | 2.112 |
| October 01, 2026 | 2.135 |
| September 30, 2026 | 2.114 |
| September 29, 2026 | 1.834 |
| September 28, 2026 | 1.810 |
| September 25, 2026 | 1.836 |
| September 24, 2026 | 1.846 |
| September 23, 2026 | 1.910 |
| September 22, 2026 | 1.980 |
| September 21, 2026 | 1.874 |
| September 18, 2026 | 1.825 |
| September 17, 2026 | 1.880 |
| September 16, 2026 | 1.812 |
| September 15, 2026 | 1.798 |
| September 14, 2026 | 1.854 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 11.52 |
| Vaxcyte, Inc. | 3.322 |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -- |
| Sarepta Therapeutics, Inc. | 0.935 |
Price to Book Value Related Metrics
| PS Ratio | 4.328 |
| Price | 8.39 |
| Earnings Yield | -14.97% |
| Market Cap | 1.421B |